Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 1235-1245

  Oda, Tomofumi ^a   Tian, Tian ^a   Inoue, Masayoshi ^a   Ikeda, Jun Ichiro ^a   Qiu, Ying ^a,b   Okumura, Meinoshin ^a   Aozasa, Katsuyuki ^a   Morii, Eiichi ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b TONGJI UNIVERSITY   (China)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ORPHAN NUCLEAR RECEPTOR NR0B1; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER STAGING; CARCINOGENICITY; CELL POPULATION; CLINICAL ASSESSMENT; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DRUG EFFECT; EPIGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SUSPENSION CELL CULTURE; TRANSCRIPTION INITIATION SITE; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 70349233884     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.090010     Document Type: Article

References (45)

1. Heppner GH: Tumor heterogeneity. Cancer Res 1984, 44:2259-2265
2. Hemburger AW, Salmon SE: Primary bioassay of human tumor stem cells. Cell Sci 1977, 197:461-463
3. Bruce WR, Van Der Gaag H: A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 1963, 199:79-80
4. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111
5. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737 (Pubitemid 27298715)
6. Lessard J, Sauvageau G: Bmi-1 determined the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423:255-260 (Pubitemid 40852690)
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988 (Pubitemid 36418143)
8. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004, 432:396-401 (Pubitemid 39551674)
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951 (Pubitemid 41713363)
10. O'Brien CA, Pollett A, Gallinger, Dick JE: A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007, 445:106-110 (Pubitemid 46067310)
11. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, DeMaria R: Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115 (Pubitemid 46067311)
12. Prince ME, Sivanandan R, Kaczorowski, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007, 104:973-978 (Pubitemid 46154721)
13. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsav V, Wicha M, Clarke MF, Simeone DM: Identification of pancreatic cancer stem cells. Cancer Res 2007, 67:1030-1037 (Pubitemid 46270758)
14. Dean M, Fojo T, Bates S: Tumor stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284 (Pubitemid 40488633)
15. Lou H, Dean M: Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene 2007, 26:1357-1360 (Pubitemid 46328461)
16. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996, 183:1797-1806 (Pubitemid 26134320)
17. Hadnagy A, Gaboury L, Beaulieu R, Balicki D: SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006, 14:387-391 (Pubitemid 44633895)
18. Kondo T, Setoguchi T, Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004, 101:781-786 (Pubitemid 38121035)
19. Setoguchi T, Taga T, Kondo T: Cancer stem cells persist in many cancer cell lines. Cell Cycle 2004, 3:414-415 (Pubitemid 40278224)
20. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005, 65:6207-6219 (Pubitemid 40994406)
21. Parkin DM, Bray F, Ferlay J, Pisani P: Global Cancer Statistics, 2002. CA Cancer J Clin 2005, 55:74-108
22. Seo DC, Sung JM, Cho HJ, Yi H, Seo KH, Choi IS, Kim DK, Kim JS, El-Aty AMA, Shin HC: Gene expression profiling of cancer stem cell in human lung adenocarcinoma A549 cells. Mol Cancer 2007, 6:75 (Pubitemid 351248078)
23. Niakan KK, McCabe ER: DAX1 origin, function, and novel role. Mol Genet Metab 2005, 86:70-83
24. Palmqvist L, Glover CH, Hsu L, Bossen B, Piret JM, Humphries RK, Helgason CD: Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells 2005, 23:663-680 (Pubitemid 40647263)
25. Niakan KK, Davis EC, Clipsham RC, Jiang M, Dehart DB, Sulik KK, McCabe ER: Novel role for the orphan nuclear receptor DAX1 in embryogenesis different from steroidogenesis. Mol Genet Metab 2006, 88:261-271 (Pubitemid 43963432)
26. Saito S, Ito K, Suzuki T, Utsunomiya H, Akahira JI, Sugihashi Y, Niikura H, Okamura K, Yaegashi N, Sasano H: Orphan nuclear receptor DAX-1 in human endometrium and its disorders. Cancer Sci 2005, 96:645-652 (Pubitemid 41723540)
27. Abd-Elaziz M, Akahira J, Moriya T, Suzuki T, Yaegashi N, Sasano H: Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome. Cancer Sci 2003, 94:980-985 (Pubitemid 37508981)
28. Nakamura Y, Suzuki T, Arai Y, Sasano H: Nuclear receptor DAX1 in human prostate cancer: a novel independent biological modulator. Endocr J 2009, 56:39-44
29. Mendiola M, Carrillo J, García E, Lalli E, Hernández T, de Alava E, Tirode F, Delattre O, García-Miguel P, López-Barea F, Pestaña A, Alonso J: The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors. Int J Cancer 2006, 118:1381-1389 (Pubitemid 43306523)
30. Kinsey M, Smith R, Lessnick SL: NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 2006, 4:851-859 (Pubitemid 44877015)
31. Morii E, Oboki K, Jippo T, Kitamura Y: Additive effect of mouse genetic background and mutation of MITF gene on decrease of skin mast cells. Blood 2003, 101:1344-1350 (Pubitemid 36182505)
32. Slichenmyer WJ, Von Hoff DD: New natural products in cancer chemotherapy. J Clin Pharmacol 1990, 30:770-788 (Pubitemid 20334336)
33. Tomicic MT, Christmann M, Kaina B: Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival. Cancer Res 2005, 65:8920-8926 (Pubitemid 41377382)
34. Meyer-Siegler KL, Iczknowski KA, Leng L, Bucala R, Vera PL: Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 2006, 177:8730-8739 (Pubitemid 44893839)
35. Guo W, Burris TP, Zhang YH, Huang BL, Mason J, Copeland KC, Kupfer SR, Pagon RA, McCabe ERB: Genomic sequence of the DAX1 gene: an orphan nuclrear receptor responsible for X-linked adrenal hypoplasia congenital and hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1996, 81:2481-2486 (Pubitemid 26240264)
36. Sobin LH, Wittekind Ch (Eds.): TNM Classification of malignant tumors. 5th ed. New York, John Wiley & Sons, Inc., 1997, pp 91-100
37. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Yokose T, Nishiwaki Y: Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. Cancer 1999, 86:1976-1984
38. Li F, Tiede B, Massague J, Kang Y: Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 2007, 17:3-14 (Pubitemid 46096419)
39. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T: Opinion: migrating cancer stem cells - an integrated concept of malignant tumor progression. Nat Rev Cancer 2005, 5:744-749
40. García-Aragoncillo E, Carrillo J, Lalli E, Agra N, Gómez-López G, Pestaña A, Alonso J: DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cell. Oncogene 2008, 27:6034-6043
41. Lalli E, Sassone-Corsi P: Dax-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol 2003, 17:1445-1453 (Pubitemid 36930462)
42. Hewitt SM, Hamada S, McDonnell TJ, Rauscher FJ 3rd, Saunders GF: Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms tumor suppressor gene WT1. Cancer Res 1995, 55:5386-5389
43. Kawajiri K, Ikuta T, Suzuki T, Kusaka M, Muramatsu M, Fujieda K, Tachibana M, Morohashi K: Role of the LXXLL-motif and activation function 2 domain in subcellular localization of Dax-1. Mol Endocrinol 2003, 17:994-1004
44. Helguero LA, Hedengran Faulds M, Förster C, Gustafsson JA, Haldosén LA: DAX-1 expression is regulated during mammary epithelial differentiation. Endocrinology 2006, 147:3249-3259 (Pubitemid 43904302)
45. Feinberg AP, Tycko B: The history of cancer epigenetics. Nat Rev Cancer 2004, 4:143-153